铁蛋白重链抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 铁蛋白重链抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Mammalian ferritins consist of 24 subunits made up of two types of poly-peptide chains, ferritin heavy chain and ferritin light chain, which each have unique functions. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of FeII, whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of FeIII. The most prominent role of mamma-lian ferritins is to provide iron-buffering 铁蛋白重链抗体capacity to cells. In addition to iron buffering, heavy chain ferritin is also involved in the regulation of thymidine biosynthesis via increased expression of cytoplasmic serine hydroxymethyltransferase, which is a limiting factor in thymidylate synthesis in MCF-7 cells. 铁蛋白重链抗体Light chain ferritin is involved in cataracts by at least two mechanisms: hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed; and oxidative stress, an important factor in the development of aging-related cataracts.

Also known as:

Apoferritin; Cell proliferation inducing gene 15 protein; F HC; Ferritin H subunit; Ferritin heavy chain; Ferritin heavy polypeptide 1; FHC; FRIH; FTH 1; FTH; FTH1; FTH1 protein; FTHL 6; FTHL6;铁蛋白重链抗体 Iron overload autosomal dominant; MGC104426; OK/SW-cl.84; PIG 15; PIG15; Placenta immunoregulatory factor; PLIF; Proliferation inducing gene 15 protein; Proliferation inducing protein 15; FRIH_HUMAN.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Rabbit, Sheep, .

●

Immunogen: KLH conjugated synthetic peptide derived from human Ferritin.

●

Predicted Molecular Weight: 21kDa.

铁蛋白重链抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl529Hu01血栓调节蛋白(TM)多克隆抗体Polyclonal Antibody to Thrombomodulin (TM)

kl529Mu01血栓调节蛋白(TM)多克隆抗体Polyclonal Antibody to Thrombomodulin (TM)

kl529Po01血栓调节蛋白(TM)多克隆抗体Polyclonal Antibody to Thrombomodulin (TM)

kl529Ra01血栓调节蛋白(TM)多克隆抗体Polyclonal Antibody to Thrombomodulin (TM)

kl529Rb51血栓调节蛋白(TM)多克隆抗体Polyclonal Antibody to Thrombomodulin (TM)

kl531Hu01纤溶酶原激活物抑制因子2(PAI2)多克隆抗体Polyclonal Antibody to Plasminogen Activator Inhibitor 2 (PAI2)

kl531Mu01纤溶酶原激活物抑制因子2(PAI2)多克隆抗体Polyclonal Antibody to Plasminogen Activator Inhibitor 2 (PAI2)

kl531Ra01纤溶酶原激活物抑制因子2(PAI2)多克隆抗体Polyclonal Antibody to Plasminogen Activator Inhibitor 2 (PAI2)

kl531Rb51纤溶酶原激活物抑制因子2(PAI2)多克隆抗体Polyclonal Antibody to Plasminogen Activator Inhibitor 2 (PAI2)

kl532Hu01纤溶酶原激活物抑制因子1(PAI1)多克隆抗体Polyclonal Antibody to Plasminogen Activator Inhibitor 1 (PAI1)

kl532Mu01纤溶酶原激活物抑制因子1(PAI1)多克隆抗体Polyclonal Antibody to Plasminogen Activator Inhibitor 1 (PAI1)

kl532Ra01纤溶酶原激活物抑制因子1(PAI1)多克隆抗体Polyclonal Antibody to Plasminogen Activator Inhibitor 1 (PAI1)

kl532Rb51纤溶酶原激活物抑制因子1(PAI1)多克隆抗体Polyclonal Antibody to Plasminogen Activator Inhibitor 1 (PAI1)

kl532Si01纤溶酶原激活物抑制因子1(PAI1)多克隆抗体Polyclonal Antibody to Plasminogen Activator Inhibitor 1 (PAI1)

kl533Hu01细胞间粘附分子3(ICAM3)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 3 (ICAM3)

kl534Hu01细胞间粘附分子2(ICAM2)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 2 (ICAM2)

kl534Mu01细胞间粘附分子2(ICAM2)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 2 (ICAM2)

kl534Rb51细胞间粘附分子2(ICAM2)多克隆抗体Polyclonal Antibody to Intercellular Adhesion Molecule 2 (ICAM2)

kl536Hu01亮氨酰氨基肽酶(LAP)多克隆抗体Polyclonal Antibody to Leucine Aminopeptidase (LAP)

kl536Ra01亮氨酰氨基肽酶(LAP)多克隆抗体Polyclonal Antibody to Leucine Aminopeptidase (LAP)